Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Commercial

Set Alert for Commercial

UK Champions Oxfordshire As Next Global Digital Health Hub

The UK government is championing the region of Oxfordshire to become the next global digital health hub post-Brexit. The ambitious plans to develop the UK’s digital health technologies were outlined at a recent event at the House of Commons in London.

United Kingdom Artificial Intelligence Digital Health
Advertisement

Companies

Set Alert for Companies

Latest From Companies

Global Device Approvals, Weekly Snapshot: FDA Approves Bard’s Venovo Stent; Abbott’s MitraClip Gets Indication-Expansion; Boston Scientific’s Watchman FLX Earns CE Mark

A snapshot of global medical device approvals captured during the past week in Medtech Insight's Approvals Tracker. This week, FDA approved Bard’s Venovo venous stent system for symptomatic iliofemoral venous outflow obstruction, FDA added functional mitral regurgitation to the approved labeling for Abbott’s market-leading MitraClip, and Watchman FLX, Boston Scientific’s next-generation left-atrial appendage closer earned a CE Mark in Europe.

Approvals Clinical Trials

Boston Scientific Encouraged By Luminize AF First-In-Human Data

Data from the AF-FICIENT I study, presented at the European Heart Rhythm Association in Lisbon, Portugal, support Boston Scientific's development of the Luminize atrial fibrillation ablation catheter. Luminize has built-in digital cameras for visual guidance and sensing electrodes on the balloon to assess real-time vein isolation.

Cardiology Clinical Trials

QUOTED. March 15, 2019. John Russell.

Cardiva Medical believes it's in a unique position to help the growing number of patients who undergo catheter-based cardiovascular procedures requiring relatively large catheters, especially electrophysiology procedures like cardiac ablation. See what Cardiva CEO John Russell said about EP procedures here.

Quoted Commercial
See All

Deals and Financings

Set Alert for Deals

Latest From Deals

AAOS 2019: OSSO VR Develops VR Training Tool For Smith & Nephew's NAVIO Robot, And More On Orthorobotics

Osso VR partnered with Smith & Nephew to develop a VR training tool that will be showcased at this year's American Association of Orthopedic Surgeons' (AAOS) conference, taking place in Las Vegas from March 12-16. Orthopedic robotic systems continue to draw high interest from surgeons. The recent US FDA clearance of Zimmer Biomet's ROSA total knee replacement system will add competition to the current market dominated by Stryker's MAKO and Smith & Nephew's NAVIO.

Commercial Deals

Medtech Money Flow: M&A & VC Deals, March 4-10, 2019 – ResMed Reels In Korean Respiratory Biz

In this week's edition of Medtech Money Flow, ResMed inks a $220M deal to buy Korean respiratory device maker HB Healthcare.

M & A Deals

Pacts In Medtech: Circassia, AIT Team Up To Treat Hypertension In Newborns; Otsuka, Click Collaborate On Depression App

Derived from Strategic Transactions, Informa's premium source for tracking life-sciences deals, the bimonthly Pacts In Medtech feature highlights notable technology alliances, R&D partnerships and commercial collaborations. This edition covers industry pacts that were sealed in January and February 2019.

Pacts in Medtech Deals
See All

Market Access

Set Alert for Market Access

Latest From Market Access

UK Medtech Market Access: More About Mindset Than The Money

The journey from medtech concept to implementation is long and slow, and new ideas often don’t make it all the way to manufacturing and approval. But when they do, what is needed is a system that guarantees adoption and usage of those proven, innovative solutions that clear the many hurdles en route to clinical practice.

Medical Device United Kingdom

“We Can’t Do It All Alone” Pfizer UK Tells Life Sciences Meeting

Incoming Pfizer UK country manager Ben Osborn outlined the delivery challenges ahead for health-care systems globally at the BioWales Showcase, in London in late February.

Medical Device Market Access

European Commission Answers Vital Questions In Second Major Brexit Response

European Commission issues Q&A document to help industry understand specifics of “placing” products on the EU market in the context of Brexit, and what needs to be done regarding responsible persons, importers and certificate transfers.

Brexit Regulation
See All

Market Intelligence

Set Alert for Market Intelligence

Latest From Market Intelligence

Market Intel: Liquid Biopsy – Ready For Prime Time?

Liquid biopsy is a rapidly developing noninvasive technology for the early detection of cancer. Multiple companies have entered clinical testing, using mostly blood to detect circulating tumor cells and/or circulating tumor DNA. But urine and even cerebral spinal fluid are promising liquids too. Regardless of the fluid, testing costs a fraction of a traditional, invasive tissue biopsy and offers much quicker results.

Commercial Innovation

Market Intel: Breast Imaging Market Driven By AI, Technological Innovation

The global market for breast cancer imaging and biopsy technologies is expected to reach $5.8bn by 2022, a CAGR of 5.9%, driven by innovation technologies and machine-learning tools that serve as "second readers" to help radiologists triage images and find cancers. Many radiologists believe that mammography will remain the most widely used screening tool, but that digital breast tomosynthesis will ultimately become the gold standard. Here's a close look at the overall breast imaging and biopsy market, highlighting different modalities and key players, and offering the real-world use perspective from three radiologists at Kaiser Permanente, San Diego.

Commercial Market Intelligence

Market Brief: Pacemaker Market Will Reach $5.3bn By 2023

The global market for implantable pacemaker products is expected to reach $5.3bn by 2023, a CAGR of 5.1% from 2017, driven by the rising aging population and growing burden of heart disease. 

Commercial Innovation
See All

Appointments

Set Alert for Appointments

Latest From Appointments

Execs On The Move: Duo Of CEOs For Nonin Medical And Contexual Genomics; New Board At ExThera Medical

Patient-monitoring company Nonin Medical and cancer genomics testing firm Contextual Genomics both hired new CEOs; blood-filtering device firm ExThera Medical appointed a scientific advisory board; and more.

Appointments Commercial

Execs On The Move: Operations Change At Misonix, A Switch From Medtronic Diabetes, And New Advice At DBV Technologies

Ultrasonic surgical platform firm Misonix appoints chief operating officer; a chief marketing officer leaves Medtronic for a place at continuous glucose monitoring system company Senseonics; food allergy biopharma firm DBV Technologies adds a scientific advisor; and more.

Appointments Commercial

QUOTED. March 12, 2019. Tim Goodnow.

Continuous glucose monitor company Senseonics Holdings Inc. has named Francine Kaufman as chief medical officer. See what Senseonics President and CEO Tim Goodnow said about Kaufman's appointment here.

Quoted Appointments
See All
UsernamePublicRestriction

Register